552 related articles for article (PubMed ID: 8467360)
41. No requirement of P2X1 purinoceptors for platelet aggregation.
Takano S; Kimura J; Matsuoka I; Ono T
Eur J Pharmacol; 1999 May; 372(3):305-9. PubMed ID: 10395026
[TBL] [Abstract][Full Text] [Related]
42. Diadenosine polyphosphates evoke Ca2+ transients in guinea-pig brain via receptors distinct from those for ATP.
Pintor J; Puche JA; Gualix J; Hoyle CH; Miras-Portugal MT
J Physiol; 1997 Oct; 504 ( Pt 2)(Pt 2):327-35. PubMed ID: 9365907
[TBL] [Abstract][Full Text] [Related]
43. Human erythroleukemic (HEL) cells express a platelet P2T-like ADP receptor.
Shi XP; Yin KC; Gardell SJ
Thromb Res; 1995 Feb; 77(3):235-47. PubMed ID: 7740516
[TBL] [Abstract][Full Text] [Related]
44. Effects of extracellular divalent cations on responses of human blood platelets to adenosine 5'-diphosphate.
Hall DA; Frost V; Hourani SM
Biochem Pharmacol; 1994 Oct; 48(7):1319-26. PubMed ID: 7945429
[TBL] [Abstract][Full Text] [Related]
45. Secreted dense granule adenine nucleotides promote calcium influx and the maintenance of elevated cytosolic calcium levels in stimulated human platelets.
Lages B; Weiss HJ
Thromb Haemost; 1999 Feb; 81(2):286-92. PubMed ID: 10064008
[TBL] [Abstract][Full Text] [Related]
46. Effects of purines on the longitudinal muscle of the rat colon.
Bailey SJ; Hourani SM
Br J Pharmacol; 1992 Apr; 105(4):885-92. PubMed ID: 1504717
[TBL] [Abstract][Full Text] [Related]
47. Adenine nucleotide analogues, including gamma-phosphate-substituted analogues, are metabolised extracellularly in innervated frog sartorius muscle.
Cascalheira JF; Sebastião AM
Eur J Pharmacol; 1992 Nov; 222(1):49-59. PubMed ID: 1468499
[TBL] [Abstract][Full Text] [Related]
48. Functional expression of a P2T ADP receptor in Xenopus oocytes injected with megakaryocyte (CMK 11-5) RNA.
Greco NJ
Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):769-77. PubMed ID: 9108793
[TBL] [Abstract][Full Text] [Related]
49. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells.
Léon C; Hechler B; Vial C; Leray C; Cazenave JP; Gachet C
FEBS Lett; 1997 Feb; 403(1):26-30. PubMed ID: 9038354
[TBL] [Abstract][Full Text] [Related]
50. Evidence for a P2-purinoceptor mediating vasoconstriction by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat.
Rubino A; Burnstock G
Br J Pharmacol; 1996 Jul; 118(6):1415-20. PubMed ID: 8832066
[TBL] [Abstract][Full Text] [Related]
51. Factors influencing the response of human blood platelets to analogues of ADP which may act as partial agonists at the ADP receptor.
Egan CM; Fisher AP; Scrutton MC
Eur J Biochem; 1979 Mar; 95(1):127-37. PubMed ID: 110586
[TBL] [Abstract][Full Text] [Related]
52. Cytoplasmic Ca2+ oscillation in rat megakaryocytes evoked by a novel type of purinoceptor.
Uneyama C; Uneyama H; Akaike N
J Physiol; 1993 Oct; 470():731-49. PubMed ID: 8308753
[TBL] [Abstract][Full Text] [Related]
53. The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.
Horner S; Menke K; Hildebrandt C; Kassack MU; Nickel P; Ullmann H; Mahaut-Smith MP; Lambrecht G
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):1-13. PubMed ID: 16158305
[TBL] [Abstract][Full Text] [Related]
54. Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo.
Humphries RG; Tomlinson W; Clegg JA; Ingall AH; Kindon ND; Leff P
Br J Pharmacol; 1995 Jul; 115(6):1110-6. PubMed ID: 7582510
[TBL] [Abstract][Full Text] [Related]
55. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL
Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the binding to fixed platelets of agonists and antagonists of ADP-induced aggregation.
Agarwal AK; Tandon NN; Greco NJ; Cusack NJ; Jamieson GA
Thromb Haemost; 1989 Dec; 62(4):1103-6. PubMed ID: 2617458
[TBL] [Abstract][Full Text] [Related]
57. Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5'-monophosphate and adenosine 5'-triphosphate of human platelet aggregation induced by adenosine 5'-diphosphate.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 Feb; 75(2):397-400. PubMed ID: 7186826
[TBL] [Abstract][Full Text] [Related]
58. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
Macfarlane DE; Srivastava PC; Mills DC
J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277
[TBL] [Abstract][Full Text] [Related]
59. Ontogeny of P2-purinoceptors in the longitudinal muscle and muscularis mucosae of the rat isolated duodenum.
Brownhill VR; Hourani SM; Kitchen I
Br J Pharmacol; 1997 Sep; 122(2):225-32. PubMed ID: 9313929
[TBL] [Abstract][Full Text] [Related]
60. Interaction of tolbutamide and cytosolic nucleotides in controlling the ATP-sensitive K+ channel in mouse beta-cells.
Schwanstecher C; Dickel C; Panten U
Br J Pharmacol; 1994 Jan; 111(1):302-10. PubMed ID: 8012711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]